Kewaunee Scientific Revenue, Profits - KEQU Quarterly Income Statement

Add to My Stocks
$26.45 $0.2 (0.76%) KEQU stock closing price Feb 21, 2018 (Closing)

Financial analysis of Kewaunee Scientific involves more than just checking the Kewaunee Scientific stock price, by looking at the financial statements of the company in detail. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue increase to $41.47M for 2018 Q2 impacts the KEQU stock. Investors typically check year over year or quarter over quarter revenue growth. The operating expenses as shown in the Kewaunee Scientific profit and loss statement for 2018 Q2 total to $5.25M. This line item shows that the operating expenses has increased compared with last year. Also check: Kewaunee Scientific assets and Kewaunee Scientific free cash flow.

View and download details of revenue and profits for Kewaunee Scientific for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is May - Apr2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Kewaunee Scientific Revenues or Net Sales
41.47M33.88M34.58M30.37M36.33M37.28M34.09M32.41M31.04M31.09M
Cost Of Goods Sold (COGS)33.56M27.06M27.26M25.33M29.22M30.14M27.25M26.92M25.5M25.24M
Kewaunee Scientific Gross Profit
7.91M6.82M7.34M5.03M7.1M7.13M6.85M5.48M5.53M5.84M
Research & Development Expense----------
Selling General & Admin Expense5.25M5.13M5.59M4.59M4.81M5.07M4.86M4.44M4.4M4.31M
Income Before Depreciation Depletion Amortization2.65M1.68M1.76M-2.28M2.06M2.01M1.04M1.12M1.52M
Depreciation Depletion Amortization----------
Non Operating Income----------
Interest Expense----------
Kewaunee Scientific Pretax Income
2.74M1.79M1.83M-2.32M2.1M1.98M1.07M1.15M1.53M
Provision for Income Taxes----------
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations1.72M1.15M1.39M-1.49M1.3M1.34M---
Extraordinary Items & Discontinued Operations----------
Kewaunee Scientific Profit/ Loss (Net Income)
1.72M1.15M1.39M-1.49M1.3M1.34M---
Average Shares used to compute Diluted EPS2.78M2.76M2.73M2.73M2.73M2.71M2.7M2.7M2.69M2.66M
Average Shares used to compute Basic EPS2.72M2.71M2.71M2.71M2.71M2.69M2.69M2.68M2.67M2.63M
Income Before Nonrecurring Items1.72M1.15M1.39M-1.49M1.3M1.34M---
Income from Nonrecurring Items----------
Kewaunee Scientific Earnings Per Share Basic Net
0.640.420.510.130.550.480.500.310.260.36
Kewaunee Scientific Earnings Per Share Diluted Net
----------
EPS Diluted Before Nonrecurring Items0.620.420.510.120.540.480.500.310.260.35
Preferred Dividends Acc Pd----------
Dividends Common0.460.41--------
Dividend Per Share Common0.170.150.150.150.150.130.130.130.130.12
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Kewaunee Scientific stock analysis involves checking at least a few of the important things like:

  • Topline: A growing topline, as seen from the Kewaunee Scientific revenue chart, as is the case with Kewaunee Scientific indicates a growing business. One needs to compare the QoQ topline or sales growth of KEQU stock with its peers like HBIO stock and MSON stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $1.72M for KEQU stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called the profit and loss statement. Apart from the KEQU income statement, one can check the Kewaunee Scientific historical stock prices to check how the price has moved with time.

Kewaunee Scientific Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
15.84
PS Ratio (price sales ratio)
0.51
Operating Margin
6.4
Net Profit Margin
4.1
Dividend Yield
2.34%